Literature DB >> 23800851

Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients.

Katherine Boyd1, Sofia M Shea, James Patterson.   

Abstract

Survival of solid organ transplant patients has been prolonged, leading to increased incidence of non-melanoma skin cancers. Metastatic squamous cell carcinoma is an increasing problem in these patients. This paper reviews the evidence available for the treatment of advanced squamous cell carcinoma with the epidermal growth factor receptor inhibitor, cetuximab.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23800851     DOI： 10.1007/s10354-013-0213-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  21 in total

Review 1.  Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.

Authors:  Juan-Carlos Martinez; Clark C Otley; Scott H Okuno; Robert L Foote; Jan L Kasperbauer
Journal:  Dermatol Surg       Date:  2004-04       Impact factor: 3.398

Review 2.  Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.

Authors:  Simon A Ritchie; Manisha J Patel; Stanley J Miller
Journal:  Dermatol Surg       Date:  2012-05-30       Impact factor: 3.398

3.  Acneiform eruption following molecular targeted chemotherapy.

Authors:  M Vaccaro; O Barbuzza; A Pollicino; C Guarneri
Journal:  Intern Med J       Date:  2011-04       Impact factor: 2.048

4.  Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy.

Authors:  T H Guthrie; E S Porubsky; M N Luxenberg; K J Shah; K L Wurtz; P R Watson
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

5.  Efficacy of cetuximab in the treatment of squamous cell carcinoma.

Authors:  Sophie Preneau; Emmanuel Rio; Anabelle Brocard; Lucie Peuvrel; Jean-Michel Nguyen; Gaelle Quéreux; Brigitte Dreno
Journal:  J Dermatolog Treat       Date:  2013-02-03       Impact factor: 3.359

6.  Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.

Authors:  Lorriana E Leard; Bryan K Cho; Kirk D Jones; Steven R Hays; Whitney D Tope; Jeffrey A Golden; Charles W Hoopes
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

7.  Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Authors:  Merrill S Kies; Floyd Christopher Holsinger; J Jack Lee; William N William; Bonnie S Glisson; Heather Y Lin; Jan S Lewin; Lawrence E Ginsberg; Katharine A Gillaspy; Erminia Massarelli; Lauren Byers; Scott M Lippman; Waun K Hong; Adel K El-Naggar; Adam S Garden; Vassiliki Papadimitrakopoulou
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

8.  Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Authors:  Julie E Bauman; Keith D Eaton; Renato G Martins
Journal:  Arch Dermatol       Date:  2007-07

9.  Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel.

Authors:  Caterina Mecca; Agostino Ponzetti; Virginia Caliendo; Libero Ciuffreda; Patrizia Lista
Journal:  Eur J Dermatol       Date:  2012 Nov-Dec       Impact factor: 3.328

10.  Cetuximab in refractory skin cancer treatment.

Authors:  Sini J Kalapurakal; James Malone; K Thomas Robbins; Lucinda Buescher; John Godwin; Krishna Rao
Journal:  J Cancer       Date:  2012-06-07       Impact factor: 4.207
View more
  1 in total

Review 1.  Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.

Authors:  Floor C J van de Watering; Mark Rijpkema; Lars Perk; Ulrich Brinkmann; Wim J G Oyen; Otto C Boerman
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.